Published in The Lancet Oncology.

Cancer survival rates even now vary widely between Europe Cancer survival even now varies widely between European countries despite major improvements in cancer medical diagnosis and treatment through the first 10 years of the 21st century, based on the latest EUROCARE-5 reviews covering over 50 percent of the adult and 77 percent of the childhood population of European countries how to take . The findings, published in The Lancet Oncology, analysed data from cancer tumor registries covering all or component of 29 countries to compare 5-year survival from analysis for more than 9 million adults and 60 415 kids diagnosed between 2000 and 2007.